文献速递白血病

维A酸 disrupts NPM1c/ROS/SENP3/ARF 致癌轴 in 急性髓系白血病

Retinoic acid disrupts an NPM1c/ROS/SENP3/ARF oncogenic axis in acute myeloid leukemia.
PubMed 文献 · Leukemia · 2025-08-26

研究在 NPM1c 急性髓系白血病细胞系及患者原始细胞中揭示:NPM1c 触发的线粒体功能障碍与氧化应激通过上调 SENP3 稳定 NPM1c;维A酸降低线粒体 ROS 产生,促使 SENP3 降解、ARF 稳定及 PML 依赖的 NPM1c 超 SUMO 化,随后经 RNF4 依赖的泛素化降解,从而打断稳定 NPM1c 的反馈环路。

要点

  • NPM1c 通过线粒体功能障碍与氧化应激上调 SENP3 稳定自身蛋白。
  • 维A酸降低线粒体 ROS,驱动 SENP3 降解与 ARF 稳定。
  • ARF 稳定导致 PML 依赖的 NPM1c 超 SUMO 化及 RNF4 依赖泛素化降解。

核心结论

  • 维A酸可打断稳定 NPM1c 蛋白的反馈环路,机制上解释维A酸在化疗或去甲基化药物治疗的 NPM1c 急性髓系白血病中的获益。

研究设计与样本

  • 研究在 NPM1c 急性髓系白血病细胞系或患者原始细胞中进行。

主要发现

  • 在 NPM1c 急性髓系白血病细胞系或患者原始细胞中,NPM1c 触发的线粒体功能障碍和氧化应激通过上调 SENP3 驱动 NPM1c 稳定。
  • 维A酸降低线粒体 ROS 产生,驱动 SENP3 降解、ARF 稳定、PML 依赖的 NPM1c 超 SUMO 化,随后经 RNF4 依赖的泛素化降解。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nucleophosmin-1 (NPM1) is a nucleolar chaperone protein frequently mutated in acute myeloid leukemia (AML). ARF and Sentrin/SUMO Specific Peptidase 3 (SENP3) control NPM1 functions through dynamic SUMOylation/de-SUMOylation. Mutated NPM1 is an oncoprotein that exhibits an aberrant cytoplasmic localization (NPM1c) and disrupts PML/P53 signaling. Studies reported increased survival of patients with NPM1c AML when retinoic acid (RA) was added to chemotherapy or hypomethylating agents. Ex vivo, RA initiates NPM1c degradation, P53 activation and cell death. Yet, the molecular mechanisms involved remain elusive. Here we show that in NPM1c AML cell lines or patients' blasts, NPM1c-triggered mitochondrial dysfunction and oxidative stress drive NPM1c stabilization through SENP3 upregulation. RA decreases mitochondrial ROS production, driving degradation of SENP3, ARF stabilization, PML-dependent NPM1c hyperSUMOylation followed by RNF4-dependent ubiquitination and degradation. Thus, the feedback loop stabilizing NPM1c protein can be interrupted by RA-triggered enhanced mitochondrial fitness, mechanistically explaining the benefit of RA in chemotherapy or hypomethylating agents-treated AMLs.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Hleihel R, Skayneh H, Wu HC, et al. Retinoic acid disrupts an NPM1c/ROS/SENP3/ARF oncogenic axis in acute myeloid leukemia. Leukemia. 2025. PMID: 40858804. doi:10.1038/s41375-025-02731-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。